Joshua Nathaniel Silverman

Age : 50

Public asset : 1,088,608 USD

Linked companies :

Ayro, Inc. -

MyMD Pharmaceuticals, Inc. -

Neurotrope, Inc. -

Protagenic Therapeutics, Inc. -

Petros Pharmaceuticals, Inc. -

Synaptogenix Inc

Summary

Joshua Nathaniel Silverman is a businessperson who founded Iroquois Capital Management LLC and Parkfield Funding LLC and who has been at the helm of 5 different companies.

He occupies the position of Chairman of Synaptogenix, Inc., Chairman of AYRO, Inc. and Chairman at Neurotrope, Inc.

He is also on the board of Protagenic Therapeutics, Inc., Crellin Capital LLC, Petros Pharmaceuticals, Inc. and MyMD Pharmaceuticals, Inc. and Managing Member at Parkfield Funding LLC.

Mr. Silverman previously was Co-Chief Investment Officer of Vertical Ventures LLC, Managing Member at Iroquois Capital Management LLC and Co-Chief Investment Officer of Iroquois Capital LP (a subsidiary of Iroquois Capital Management LLC), Chairman for Akers Biosciences, Inc. and Chairman for DropCar, Inc.

Mr. Silverman received an undergraduate degree from Lehigh University.

Current positions of Joshua Nathaniel Silverman

Name	Title	Since
Ayro, Inc. (Auto & Truck Manufacturers)	Chairman	2020
MyMD Pharmaceuticals, Inc. (Medical Equipment, Supplies & Distribution)	Director	-
Neurotrope, Inc.	Chairman	2016
Protagenic Therapeutics, Inc. (Biotechnology & Medical Research)	Independent Non-Executive Director	2016
Petros Pharmaceuticals, Inc. (Biotechnology & Medical Research)	Vice Chairman	2020
Synaptogenix Inc	Chairman	2016
Crellin Capital LLC	Director	-
Parkfield Funding LLC	Managing Member	2016

Holdings of Joshua Nathaniel Silverman

Name	Equities	%	Valuation
Ayro, Inc. (AYRO) (Auto & Truck Manufacturers)	136,467	0.39%	667,324 USD
MyMD Pharmaceuticals, Inc. (MYMD)	71,175	0.19%	311,035 USD
Synaptogenix, Inc. (SNPX)	15,000	0.43%	110,250 USD
Protagenic Therapeutics, Inc. (PTIX) (Biotechnology & Medical Research)	0	0.0000%	0 USD

Joshua Nathaniel Silverman: Personal Network

Name	Linked companies
Robert C. Schroeder	MyMD Pharmaceuticals, Inc.
Christopher C. Chapman	MyMD Pharmaceuticals, Inc.
Bill Joe White	MyMD Pharmaceuticals, Inc.
Craig Eagle	MyMD Pharmaceuticals, Inc.
Ian Rhodes	MyMD Pharmaceuticals, Inc.
Paul Rivard	MyMD Pharmaceuticals, Inc.
Jude Uzonwanne	MyMD Pharmaceuticals, Inc.
Adam Kaplin	MyMD Pharmaceuticals, Inc.
Bruce Todd Bernstein	Synaptogenix, Inc. Neurotrope, Inc. Petros Pharmaceuticals, Inc.
Alan J. Tuchman	Synaptogenix, Inc. Neurotrope, Inc.